Chronic myeloid leukemia (CML) is characterized by the BCR::ABL1 oncoprotein, which produces a constitutively active tyrosine kinase that leads to pathogenesis (Heisterkamp et al. 1983). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.